Alison Layton

11.2k total citations · 1 hit paper
179 papers, 6.1k citations indexed

About

Alison Layton is a scholar working on Dermatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alison Layton has authored 179 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Dermatology, 24 papers in Epidemiology and 16 papers in Infectious Diseases. Recurrent topics in Alison Layton's work include Acne and Rosacea Treatments and Effects (116 papers), Dermatology and Skin Diseases (64 papers) and Skin Protection and Aging (33 papers). Alison Layton is often cited by papers focused on Acne and Rosacea Treatments and Effects (116 papers), Dermatology and Skin Diseases (64 papers) and Skin Protection and Aging (33 papers). Alison Layton collaborates with scholars based in United Kingdom, United States and Canada. Alison Layton's co-authors include W.J. Cunliffe, W.J. Cunliffe, Brigitte Dréno, Diane Thiboutot, E. Anne Eady, C. A. Henderson, W.J. Cunliffe, Harald Gollnick, Jerry Tan and Christina Williams and has published in prestigious journals such as The Lancet, Nature Medicine and Nature Communications.

In The Last Decade

Alison Layton

165 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European evidence‐based (S3) guideline for the treatment of acne – update 2016 – short version

2016 228 citations Brigitte Dréno, Vincenzo Bettoli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Layton United Kingdom	42	4.6k	1.1k	650	542	516	179	6.1k
Guy Webster United States	42	3.8k 0.8×	889 0.8×	1.1k 1.6×	375 0.7×	508 1.0×	167	5.3k
Devinder Mohan Thappa India	32	1.6k 0.4×	586 0.5×	953 1.5×	552 1.0×	363 0.7×	361	4.2k
Inderjeet Kaur India	31	1.1k 0.2×	640 0.6×	725 1.1×	711 1.3×	554 1.1×	202	3.6k
Nanette B. Silverberg United States	38	2.0k 0.4×	958 0.9×	777 1.2×	248 0.5×	247 0.5×	190	4.1k
W.J. Cunliffe United Kingdom	29	2.4k 0.5×	461 0.4×	420 0.6×	272 0.5×	372 0.7×	84	3.1k
Sunil Dogra India	36	1.5k 0.3×	793 0.7×	1.8k 2.7×	982 1.8×	384 0.7×	347	5.0k
Jürgen Schauber Germany	40	2.2k 0.5×	325 0.3×	711 1.1×	334 0.6×	1.8k 3.5×	83	6.3k
Regina Fölster‐Holst Germany	38	4.0k 0.9×	250 0.2×	386 0.6×	284 0.5×	587 1.1×	200	5.6k
Kabir Sardana India	28	1.2k 0.3×	702 0.7×	1.2k 1.8×	532 1.0×	228 0.4×	242	3.0k
Noah Scheinfeld United States	34	1.5k 0.3×	263 0.2×	981 1.5×	369 0.7×	509 1.0×	191	4.0k

Countries citing papers authored by Alison Layton

Since Specialization

Citations

This map shows the geographic impact of Alison Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Layton more than expected).

Fields of papers citing papers by Alison Layton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Layton. The network helps show where Alison Layton may publish in the future.

Co-authorship network of co-authors of Alison Layton

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Layton. A scholar is included among the top collaborators of Alison Layton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Layton. Alison Layton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Layton, Alison, et al.. (2025). Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites. British Journal of Dermatology. 193(2). 267–275. 1 indexed citations

Layton, Alison, et al.. (2025). The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review. American Journal of Clinical Dermatology. 27(1). 17–47.

Ranasinghe, Shalindra, Charles Lacey, Hiro Goto, et al.. (2024). Development of a Core Outcome Measure Instrument; "LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis. PLoS neglected tropical diseases. 18(8). e0012393–e0012393. 1 indexed citations

Santer, Miriam, Beth Stuart, Tracey Sach, et al.. (2024). Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technology Assessment. 28(56). 1–86. 5 indexed citations

Younis, Brima M., Rebecca Wiggins, Eltahir Awad Gasim Khalil, et al.. (2024). A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis. Molecular Therapy — Methods & Clinical Development. 32(3). 101310–101310. 1 indexed citations

Layton, Alison, Andrew Alexis, Hilary Baldwin, et al.. (2023). The Personalized Acne Treatment Tool — Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of Experts. JAAD International. 12. 60–69. 11 indexed citations

Eminton, Zina, Jacqueline Nuttall, Christopher R Wilcox, et al.. (2023). Factors that influence women’s enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial. Trials. 24(1). 661–661. 1 indexed citations

Layton, Alison & Marco Rocha. (2023). Real-World Case Studies Showing the Effective Use of Azelaic Acid in the Treatment, and During the Maintenance Phase, of Adult Female Acne Patients. Clinical Cosmetic and Investigational Dermatology. Volume 16. 515–527. 4 indexed citations

Santer, Miriam, Zina Eminton, Beth Stuart, et al.. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 381. e074349–e074349. 25 indexed citations

10.

Ashwin, Helen, Jovana Sádlová, Barbora Vojtková, et al.. (2021). Characterization of a new Leishmania major strain for use in a controlled human infection model. Nature Communications. 12(1). 215–215. 34 indexed citations

11.

Stuart, Beth, Ingrid Müller, Alison Layton, et al.. (2021). Patient-reported outcome measures for acne: a mixed-methods validation study (acne PROMs). BMJ Open. 11(3). e034047–e034047. 8 indexed citations

12.

Tan, Jerry, Stefan Beissert, Fran Cook-Bolden, et al.. (2021). Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study. JAAD International. 6. 43–50. 19 indexed citations

13.

Wade, Ros, Alexis Llewellyn, Julie Jones-Diette, et al.. (2018). Interventional management of hyperhidrosis in secondary care: a systematic review. British Journal of Dermatology. 179(3). 599–608. 20 indexed citations

14.

Abbott, Rachel, Paul Posadzki, Mate Car, et al.. (2017). Light therapies for acne: abridged Cochrane systematic review including GRADE assessments. British Journal of Dermatology. 178(1). 61–75. 29 indexed citations

15.

Homburg, Roy, Anil Gudi, Amit Shah, & Alison Layton. (2017). A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study. Reproductive Biology and Endocrinology. 15(1). 61–61. 38 indexed citations

16.

Wade, Ros, Stephen Rice, Alexis Llewellyn, et al.. (2017). Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis. Health Technology Assessment. 21(80). 1–280. 11 indexed citations

17.

Layton, Alison, N. J. Levell, Matthew J Ridd, et al.. (2015). Identifying acne treatment uncertainties \nvia a James Lind Alliance Priority \nSetting Partnership. University of Huddersfield Repository (University of Huddersfield). 40 indexed citations

18.

Eady, E. Anne, Alison Layton, & Jonathan H. Cove. (2013). A Honey Trap for the Treatment of Acne: Manipulating the Follicular Microenvironment to Control Propionibacterium acnes. BioMed Research International. 2013. 1–8. 14 indexed citations

19.

Layton, Alison & J.A. COTTERILL. (1993). A case of Achenbach's syndrome. Clinical and Experimental Dermatology. 18(1). 60–61. 17 indexed citations

20.

Luck, James V., Alison Layton, & B A Noble. (1992). Necrobiotic xanthogranuloma with orbital involvement.. PubMed Central. 85(6). 357–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact